FDA Approved Drugs Efavirenz, Tipranavir, and Dasabuvir Inhibit Replication of Multiple Flaviviruses In Vitro

FDA Approved Drugs Efavirenz, Tipranavir, and Dasabuvir Inhibit Replication of Multiple Flaviviruses In Vitro

Arthropod-borne flaviviruses such as tick-borne encephalitis virus (TBEV), West Nile virus (WNV), Zika virus (ZIKV), Dengue virus (DENV), and yellow fever virus (YFV) cause several serious life-threatening syndromes (encephalitis, miscarriages, paralysis, etc.). No effective antiviral therapy agains...

Full description

Bibliographic Details
Main Authors: Michal Stefanik, Fortunatus C Ezebuo, Jan Haviernik, Ikemefuna C. Uzochukwu, Martina Fojtikova, Jiri Salat, Ludek Eyer, Daniel Ruzek
Format: Article
Language:English
Published: MDPI AG 2020-06-01
Series:Proceedings
Subjects:
flaviviruses
dasabuvir
tipranavir
efavirenz
antiviral drug
Online Access:https://www.mdpi.com/2504-3900/50/1/6

Internet

https://www.mdpi.com/2504-3900/50/1/6

Similar Items